• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHEST评分对老年COVID-19患者的死亡预测价值——COLOS研究的亚分析

Mortality Predictive Value of the CHEST Score in Elderly Subjects with COVID-19-A Subanalysis of the COLOS Study.

作者信息

Rola Piotr, Doroszko Adrian, Trocha Małgorzata, Giniewicz Katarzyna, Kujawa Krzysztof, Skarupski Marek, Gawryś Jakub, Matys Tomasz, Szahidewicz-Krupska Ewa, Gajecki Damian, Adamik Barbara, Kaliszewski Krzysztof, Kilis-Pstrusinska Katarzyna, Letachowicz Krzysztof, Matera-Witkiewicz Agnieszka, Pomorski Michał, Protasiewicz Marcin, Majchrzak Konrad, Sokołowski Janusz, Jankowska Ewa Anita, Madziarska Katarzyna

机构信息

Department of Cardiology, Provincial Specialized Hospital, Iwaszkiewicza 5 Str., 59-220 Legnica, Poland.

Clinical Department of Internal Medicine, Hypertension and Clinical Oncology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.

出版信息

J Clin Med. 2022 Feb 14;11(4):992. doi: 10.3390/jcm11040992.

DOI:
10.3390/jcm11040992
PMID:35207272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8879688/
Abstract

UNLABELLED

Senility has been identified among the strongest risk predictors for unfavorable COVID-19-outcome. However, even in the elderly population, the clinical course of infection in individual patients remains unpredictable. Hence, there is an urgent need for developing a simple tool predicting adverse COVID-19-outcomes. We assumed that the C2HEST-score could predict unfavorable clinical outcomes in the elderly subjects with COVID-19-subjects.

METHODS

We retrospectively analyzed 1047 medical records of patients at age > 65 years, hospitalized at the medical university center due to COVID-19. Subsequently, patients were divided into three categories depending on their C2HEST-score result.

RESULTS

We noticed significant differences in the and 3- and 6- mortality-which was the highest in --C2HEST-stratum reaching 35.7%, 54.4%, and 65.9%, respectively. The -stratum mortalities reached 24.1% 43.4%, and 57.6% and for -stratum 14.4%, 25.8%, and 39.2% respectively. In the C2HEST-score model, a change from the to the category increased the probability of death intensity approximately two-times. Subsequently, transfer from the to the -stratum raised all-cause-death-intensity 2.7-times. Analysis of the secondary outcomes revealed that the C2HEST-score has predictive value for acute kidney injury, acute heart failure, and cardiogenic shock.

CONCLUSIONS

C2HEST-score analysis on admission to the hospital may predict the mortality, acute kidney injury, and acute heart failure in elderly subjects with COVID-19.

摘要

未标注

衰老已被确定为新冠病毒病不良预后的最强风险预测因素之一。然而,即使在老年人群中,个体患者的感染临床过程仍然不可预测。因此,迫切需要开发一种简单的工具来预测新冠病毒病的不良预后。我们假设C2HEST评分可以预测新冠病毒病老年患者的不良临床结局。

方法

我们回顾性分析了1047例65岁以上因新冠病毒病在医科大学中心住院患者的病历。随后,根据患者的C2HEST评分结果将其分为三类。

结果

我们注意到在3个月和6个月死亡率方面存在显著差异——在C2HEST评分最高的组中死亡率最高,分别达到35.7%、54.4%和65.9%。中等评分组的死亡率分别达到24.1%、43.4%和57.6%,低评分组分别为14.4%、25.8%和39.2%。在C2HEST评分模型中,从低评分组变为中等评分组会使死亡强度概率增加约两倍。随后,从中等评分组转为高评分组会使全因死亡强度增加2.7倍。对次要结局的分析表明,C2HEST评分对急性肾损伤、急性心力衰竭和心源性休克具有预测价值。

结论

入院时进行C2HEST评分分析可预测新冠病毒病老年患者的死亡率、急性肾损伤和急性心力衰竭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/68e4dd9e94ba/jcm-11-00992-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/7a9c897135b7/jcm-11-00992-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/02fe48690a4f/jcm-11-00992-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/ab76da0e1194/jcm-11-00992-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/68e4dd9e94ba/jcm-11-00992-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/7a9c897135b7/jcm-11-00992-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/02fe48690a4f/jcm-11-00992-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/ab76da0e1194/jcm-11-00992-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9984/8879688/68e4dd9e94ba/jcm-11-00992-g004.jpg

相似文献

1
Mortality Predictive Value of the CHEST Score in Elderly Subjects with COVID-19-A Subanalysis of the COLOS Study.CHEST评分对老年COVID-19患者的死亡预测价值——COLOS研究的亚分析
J Clin Med. 2022 Feb 14;11(4):992. doi: 10.3390/jcm11040992.
2
Sex-Dependent Differences in Predictive Value of the CHEST Score in Subjects with COVID-19-A Secondary Analysis of the COLOS Study.COVID-19患者中CHEST评分预测价值的性别差异——COLOS研究的二次分析
Viruses. 2022 Mar 17;14(3):628. doi: 10.3390/v14030628.
3
Usefulness of CHEST Score in Predicting Clinical Outcomes of COVID-19 in Heart Failure and Non-Heart-Failure Cohorts.CHEST评分在预测心力衰竭和非心力衰竭队列中COVID-19临床结局方面的效用。
J Clin Med. 2022 Jun 17;11(12):3495. doi: 10.3390/jcm11123495.
4
Usefulness of the CHEST Score in Predicting the Clinical Outcomes of COVID-19 in Diabetic and Non-Diabetic Cohorts.CHEST评分在预测糖尿病和非糖尿病队列中COVID-19临床结局方面的实用性。
J Clin Med. 2022 Feb 7;11(3):873. doi: 10.3390/jcm11030873.
5
The Usefulness of the CHEST Risk Score in Predicting Clinical Outcomes among Hospitalized Subjects with COVID-19 and Coronary Artery Disease.COVID-19 与冠状动脉疾病住院患者临床结局预测中 CHEST 风险评分的作用。
Viruses. 2022 Aug 14;14(8):1771. doi: 10.3390/v14081771.
6
The Usefulness of the CHEST Score in Predicting the Clinical Outcomes of COVID-19 in COPD and Non-COPD Cohorts.CHEST评分在预测慢性阻塞性肺疾病(COPD)和非COPD队列中COVID-19临床结局方面的效用
Microorganisms. 2024 Jun 20;12(6):1238. doi: 10.3390/microorganisms12061238.
7
Refining age stratum of the CHEST score for predicting incident atrial fibrillation in a hospital-based Chinese population.优化 CHEST 评分的年龄分层在中国医院人群中预测新发心房颤动的价值。
Eur J Intern Med. 2021 Aug;90:37-42. doi: 10.1016/j.ejim.2021.04.014. Epub 2021 May 10.
8
CHEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial.CHEST 评分可预测射血分数保留型心力衰竭的临床结局:TOPCAT 试验的二次分析。
BMC Med. 2021 Feb 18;19(1):44. doi: 10.1186/s12916-021-01921-w.
9
C HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.CHEST 评分与中风后患者心房颤动事件的预测:一项法国全国性研究。
J Am Heart Assoc. 2019 Jul 2;8(13):e012546. doi: 10.1161/JAHA.119.012546. Epub 2019 Jun 25.
10
Evaluation of the CHEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study).评估 CHEST 风险评分作为健康人群中偶发性心房颤动的可能机会性筛查工具(来自全国丹麦队列研究)。
Am J Cardiol. 2020 Jan 1;125(1):48-54. doi: 10.1016/j.amjcard.2019.09.034. Epub 2019 Oct 10.

引用本文的文献

1
Multiparametric Outcome Assessment After Transcatheter Aortic Valve Implantation-A Systematic Review.经导管主动脉瓣植入术后的多参数结局评估——一项系统评价
J Clin Med. 2025 Feb 20;14(5):1426. doi: 10.3390/jcm14051426.
2
Usefulness of the Veterans Health Administration COVID-19 (VACO) Index for Predicting Short-Term Mortality among Patients of the COLOS Study.退伍军人健康管理局COVID-19(VACO)指数对COLOS研究患者短期死亡率的预测价值。
J Clin Med. 2023 Sep 28;12(19):6262. doi: 10.3390/jcm12196262.
3
Clinical Features of COVID-19 in Elderly Patients: Tools for Predicting Outcomes Are Needed.

本文引用的文献

1
Association of health vulnerability with adverse outcomes in older people with COVID-19: a prospective cohort study.健康脆弱性与 COVID-19 老年患者不良结局的关联:一项前瞻性队列研究。
Clinics (Sao Paulo). 2021 Dec 6;76:e3369. doi: 10.6061/clinics/2021/e3369. eCollection 2021.
2
Thyroid disease and hypothyroidism are associated with poor COVID-19 outcomes: A systematic review, meta-analysis, and meta-regression.甲状腺疾病和甲状腺功能减退症与 COVID-19 不良结局相关:系统评价、荟萃分析和荟萃回归。
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102312. doi: 10.1016/j.dsx.2021.102312. Epub 2021 Oct 22.
3
Characteristics, hospital referrals and 60-day mortality of older patients living in nursing homes with COVID-19 assessed by a liaison geriatric team during the first wave: a research article.
老年 COVID-19 患者的临床特征:需要预测预后的工具。
J Clin Med. 2022 Dec 18;11(24):7505. doi: 10.3390/jcm11247505.
4
The Usefulness of the CHEST Risk Score in Predicting Clinical Outcomes among Hospitalized Subjects with COVID-19 and Coronary Artery Disease.COVID-19 与冠状动脉疾病住院患者临床结局预测中 CHEST 风险评分的作用。
Viruses. 2022 Aug 14;14(8):1771. doi: 10.3390/v14081771.
5
Usefulness of CHEST Score in Predicting Clinical Outcomes of COVID-19 in Heart Failure and Non-Heart-Failure Cohorts.CHEST评分在预测心力衰竭和非心力衰竭队列中COVID-19临床结局方面的效用。
J Clin Med. 2022 Jun 17;11(12):3495. doi: 10.3390/jcm11123495.
在第一波疫情期间,由老年病联络团队评估的入住养老院的新冠肺炎老年患者的特征、医院转诊情况及60天死亡率:一篇研究文章。
BMC Geriatr. 2021 Oct 29;21(1):610. doi: 10.1186/s12877-021-02565-4.
4
The Effects of Previous Asthma and COPD on the Susceptibility to and Severity of COVID-19: A Nationwide Cohort Study in South Korea.既往哮喘和慢性阻塞性肺疾病对新型冠状病毒肺炎易感性及严重程度的影响:韩国一项全国性队列研究
J Clin Med. 2021 Oct 9;10(20):4626. doi: 10.3390/jcm10204626.
5
Comfort rules for face masks among healthcare workers during COVID-19 spread.COVID-19 传播期间医护人员佩戴口罩的舒适度准则。
Ann Ig. 2021 Nov-Dec;33(6):615-627. doi: 10.7416/ai.2021.2439. Epub 2021 Apr 2.
6
COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis.慢性阻塞性肺疾病与新冠病毒病不良结局风险:一项系统评价与荟萃分析
EClinicalMedicine. 2021 Mar;33:100789. doi: 10.1016/j.eclinm.2021.100789. Epub 2021 Mar 18.
7
CHEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial.CHEST 评分可预测射血分数保留型心力衰竭的临床结局:TOPCAT 试验的二次分析。
BMC Med. 2021 Feb 18;19(1):44. doi: 10.1186/s12916-021-01921-w.
8
Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis.高血压是 COVID-19 患者发生重症和死亡的一个重要临床危险因素:一项荟萃分析。
Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):745-755. doi: 10.1016/j.numecd.2020.12.009. Epub 2020 Dec 11.
9
Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients.白细胞介素-8 作为 2019 年冠状病毒病患者疾病预后的生物标志物。
Front Immunol. 2021 Jan 8;11:602395. doi: 10.3389/fimmu.2020.602395. eCollection 2020.
10
Prognostic Factors at Admission for In-Hospital Mortality from COVID-19 Infection in an Older Rural Population in Central Spain.西班牙中部老年农村人口中新冠病毒感染患者住院期间死亡的入院时预后因素
J Clin Med. 2021 Jan 16;10(2):318. doi: 10.3390/jcm10020318.